1. Home
  2. FNWB vs MXCT Comparison

FNWB vs MXCT Comparison

Compare FNWB & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$9.13

Market Cap

87.5M

Sector

Finance

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$0.78

Market Cap

86.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
MXCT
Founded
1923
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.5M
86.5M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
FNWB
MXCT
Price
$9.13
$0.78
Analyst Decision
Buy
Buy
Analyst Count
1
4
Target Price
$13.50
$7.50
AVG Volume (30 Days)
27.4K
1.3M
Earning Date
04-29-2026
04-06-2026
Dividend Yield
0.76%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$176,000.00
$38,627,000.00
Revenue This Year
$19.24
N/A
Revenue Next Year
$8.90
$9.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.05
$0.64
52 Week High
$10.98
$3.49

Technical Indicators

Market Signals
Indicator
FNWB
MXCT
Relative Strength Index (RSI) 29.81 39.34
Support Level $7.56 $0.75
Resistance Level $9.50 $1.79
Average True Range (ATR) 0.31 0.06
MACD -0.09 0.03
Stochastic Oscillator 5.86 57.77

Price Performance

Historical Comparison
FNWB
MXCT

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Share on Social Networks: